amyotrophic lateral sclerosis therapy (Verge Genomics/Eli Lilly)

N/A

Report date: 2025/03/14 16:40:41
NME

Base Information

Drug Nameamyotrophic lateral sclerosis therapy (Verge Genomics/Eli Lilly)
Drug Alias Nameamyotrophic lateral sclerosis therapy (Verge Genomics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVerge Genomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyVerge Genomics Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A